Omega Healthcare Investors (NYSE:OHI) Issues Earnings Results, Misses Estimates By $0.20 EPS

Omega Healthcare Investors (NYSE:OHI) issued its earnings results on Tuesday. The real estate investment trust reported $0.27 earnings per share for the quarter, missing analysts’ consensus estimates of $0.47 by ($0.20), FiscalAI reports. The firm had revenue of $340.55 million during the quarter, compared to analyst estimates of $269.16 million. Omega Healthcare Investors had a net margin of 66.96% and a return on equity of 15.76%.

Omega Healthcare Investors Stock Performance

Shares of OHI stock traded up $0.60 during trading hours on Tuesday, reaching $47.60. The company had a trading volume of 3,333,271 shares, compared to its average volume of 2,072,478. The company has a market capitalization of $14.42 billion, a P/E ratio of 17.00, a price-to-earnings-growth ratio of 1.84 and a beta of 0.56. Omega Healthcare Investors has a twelve month low of $41.53 and a twelve month high of $52.39. The stock’s fifty day simple moving average is $46.18 and its 200 day simple moving average is $46.63.

Omega Healthcare Investors Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Monday, November 16th. Stockholders of record on Thursday, November 5th will be paid a $0.68 dividend. The ex-dividend date is Thursday, November 5th. This represents a $2.72 dividend on an annualized basis and a dividend yield of 5.7%. Omega Healthcare Investors’s dividend payout ratio (DPR) is 97.14%.

Wall Street Analyst Weigh In

OHI has been the topic of several research analyst reports. Mizuho lifted their price objective on Omega Healthcare Investors from $45.00 to $46.00 and gave the company a “neutral” rating in a research note on Monday, August 31st. Citizens Jmp raised shares of Omega Healthcare Investors from a “market perform” rating to a “market outperform” rating and set a $52.00 target price for the company in a research report on Thursday, October 22nd. Citigroup upgraded shares of Omega Healthcare Investors from a “buy” rating to an “outperform” rating in a report on Thursday, October 22nd. Weiss Ratings reaffirmed a “buy (b+)” rating on shares of Omega Healthcare Investors in a research report on Friday, September 25th. Finally, Cantor Fitzgerald boosted their price objective on shares of Omega Healthcare Investors from $52.00 to $56.00 and gave the stock an “overweight” rating in a research note on Friday, July 31st. Seven analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $49.93.

About Omega Healthcare Investors

Omega Healthcare Investors, Inc is a real estate investment trust focused on the healthcare sector. The company invests in and owns healthcare facilities, with a primary emphasis on skilled nursing and assisted living properties.

Omega generally leases its properties to healthcare operators under long-term agreements, supporting services for seniors and individuals who require post-acute, rehabilitative, or long-term care. Its portfolio has also included other healthcare-related properties, such as continuing care retirement communities and specialty facilities.

Founded in 1992 and headquartered in Hunt Valley, Maryland, Omega serves healthcare operators across the United States and the United Kingdom.